A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

In today's fast-paced world, respiratory health is often neglected, especially for those suffering from chronic conditions ...

Elderly residents with mobility issues say they are "stuck in their homes" after a retirement apartment block's lift has ...

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

Jan. 21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising concerns for the efficacy of these medications for maternal ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

In the study, Nucala was added to inhaled maintenance therapy for ... in the first half of this year, up 15%. COPD could open up a massive new market for the drug, which still has several years ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...